title: VI. FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysis.
authors.affiliation: LYSA Imaging, Department of Nuclear Medicine, Henri Mondor University Hospital, Créteil, France.
authors.forename: Michel
authors.initials: M
authors.lastname: Meignan
mesh_terms: D014408:Biomarkers, Tumor; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging*; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods*; D011859:Radiography; D019275:Radiopharmaceuticals / Q000627:therapeutic use*
chemical_list: D014408:Biomarkers, Tumor; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: FDG; Lymphoma; PET; metabolic volume